A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)

计划入组 120 人 · 首次发布于 2023 年 3 月 16 日

A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus Infection

计划入组 54 人 · 首次发布于 2021 年 3 月 4 日

ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection

计划入组 120 人 · 首次发布于 2026 年 5 月 7 日

Peginterferon alpha-2b（Vir Biotechnology）

MSC-IFNα

ATP-IFNα

Per Humpert

Germany

PPG Industries

United States

Curium PET France

France

Brii Bio's BRII-179 Shows Promise in Identifying Responders for HBV Functional Cure

Brii Biosciences' Combination Therapy Shows Promise for Hepatitis B Functional Cure in Phase 2 Study

Bulevirtide Monotherapy Shows Sustained Safety and Tolerability in Chronic Hepatitis Delta